The Valley Desk

NCT03459443 · Interventional trial

A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471

Overall registry status Terminated

Phase 2

Conditions C3 Glomerulonephritis, C3 Glomerulopathy, Dense Deposit Disease, IC-MPGN, Immune Complex Membranoproliferative Glomerulonephritis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov